XML 61 R40.htm IDEA: XBRL DOCUMENT v2.4.0.6
Stock-Based Compensation (Tables)
12 Months Ended
Dec. 31, 2011
Disclosure of Compensation Related Costs, Share-based Payments [Abstract]  
Schedule of assumptions used relating to valuation of stock options
The following table summarizes the assumptions used relating to the valuation of our stock options during 2011, 2010, and 2009:
 
Grant Year
 
2011
 
2010
 
2009
Risk-free interest rate
0.62% - 2.81%

 
1.18% - 3.24%

 
1.64% - 3.36%

Expected dividend yield

 

 

Expected term
4 -7 years

 
4 -7 years

 
4 - 7 years

Expected volatility
39% - 50%

 
40% - 49%

 
42% - 52%

Schedule of stock option activity
The following table summarizes stock option activity during 2011:
 
Stock Options
 
Shares
(in millions)
 
Weighted-
Average
Exercise Price
 
Weighted-
Average
Remaining
Contractual
Term (Years)
 
Aggregate
Intrinsic Value
(in millions)
Options outstanding at January 1
10.1

 
$
17.92

 
 
 
 
Granted (1)
1.2

 
$
35.84

 
 
 
 
Exercised
(4.4
)
 
$
17.74

 
 
 
 
Forfeited
(0.1
)
 
$
20.23

 
 
 
 
Expired

 
$

 
 
 
 
Options outstanding as of December 31
6.8

 
$
21.03

 
6.5

 
$
108.7

Options exercisable at December 31
4.2

 
$
18.91

 
5.4

 
$
75.7

Options exercisable at December 31 and expected to vest thereafter
6.7

 
$
20.94

 
6.4

 
$
108.2

Options available for future grants at December 31
8.1

 
 
 
 
 
 
(1) 
The options granted during 2011, are related to our employee and non-employee director quarterly stock option award grants in March, June, September, and December 2011.
Schedule of weighted average grant-date fair value of stock options granted and total intrinsic value of stock options exercised
The weighted average grant-date fair value of stock options granted and total intrinsic value of stock options exercised are summarized in the following table:
 
 
(In millions, except per option data)
2011
 
2010
 
2009
Weighted average grant-date fair value of stock options granted
$
15.69

 
$
9.57

 
$
7.30

Total intrinsic value of stock options exercised
$
81.0

 
$
24.8

 
$
19.5

Schedule of vested and unvested restricted stock
The following table summarizes information about vested and unvested restricted stock for 2011:
 
Restricted Stock
 
Shares
(in millions)
 
Weighted-Average
Grant Date
Fair Value
Nonvested at January 1
0.4

 
$
13.78

Granted (2)
0.2

 
$
32.50

Vested
(0.2
)
 
$
14.99

Forfeited

 
$

Nonvested at December 31
0.4

 
$
21.17

(2) 
The restricted stock awards granted during 2011 are related to our employee annual restricted stock award grant in March 2011.
Schedule of weighted average grant-date fair value of restricted stock awards granted and total fair value of restricted stock awards vested
The weighted average grant-date fair value of restricted stock awards granted and total fair value of restricted stock awards vested are summarized in the following table:
 
 
(In millions, except per share data)
2011
 
2010
 
2009
Weighted average grant-date fair value of restricted stock awards granted
$
32.50

 
$
18.20

 
$
9.97

Total fair value of restricted stock awards vested
$
5.5

 
$
2.2

 
$
1.0

Schedule of total stock-based compensation expense
The following table summarizes the total stock-based compensation expense recognized in Selling, General, and Administrative Expenses in the Consolidated Income Statements and the total recognized tax benefit related thereto:
 
2011
 
2010
 
2009
Stock options
$
15.2

 
$
14.0

 
$
12.5

Restricted stock
3.2

 
1.9

 
1.0

Total stock-based compensation expense
$
18.4

 
$
15.9

 
$
13.5

 
 
 
 
 
 
Tax benefit related to stock-based compensation expense
$
7.0

 
$
6.1

 
$
5.1